These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12218712

  • 1. Longitudinal personality changes among presymptomatic Huntington disease gene carriers.
    Kirkwood SC, Siemers E, Viken R, Hodes ME, Conneally PM, Christian JC, Foroud T.
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Sep; 15(3):192-7. PubMed ID: 12218712
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales.
    Close Kirkwood S, Siemers E, Viken RJ, Hodes ME, Conneally PM, Christian JC, Foroud T.
    J Psychiatr Res; 2002 Sep; 36(6):377-82. PubMed ID: 12393306
    [Abstract] [Full Text] [Related]

  • 3. Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease.
    Vassos E, Panas M, Kladi A, Vassilopoulos D.
    Biol Psychiatry; 2007 Dec 15; 62(12):1347-52. PubMed ID: 17610848
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers.
    Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, Foroud T.
    Arch Neurol; 1999 May 15; 56(5):563-8. PubMed ID: 10328251
    [Abstract] [Full Text] [Related]

  • 5. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J, White K, Weaver M, Flury Wetherill L, Hui S, Stout JC, Johnson SA, Beristain X, Gray J, Wojcieszek J, Foroud T.
    Arch Neurol; 2007 Jan 15; 64(1):116-21. PubMed ID: 17210818
    [Abstract] [Full Text] [Related]

  • 6. Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers.
    Farrow M, Chua P, Churchyard A, Bradshaw JL, Chiu E, Georgiou-Karistianis N.
    Cogn Behav Neurol; 2006 Dec 15; 19(4):208-16. PubMed ID: 17159618
    [Abstract] [Full Text] [Related]

  • 7. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene.
    Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T.
    Arch Neurol; 2000 Jul 15; 57(7):1040-4. PubMed ID: 10891987
    [Abstract] [Full Text] [Related]

  • 8. Saccades in presymptomatic and early stages of Huntington disease.
    Blekher T, Johnson SA, Marshall J, White K, Hui S, Weaver M, Gray J, Yee R, Stout JC, Beristain X, Wojcieszek J, Foroud T.
    Neurology; 2006 Aug 08; 67(3):394-9. PubMed ID: 16855205
    [Abstract] [Full Text] [Related]

  • 9. Visual function in Huntington's disease patients and presymptomatic gene carriers.
    O'Donnell BF, Wilt MA, Hake AM, Stout JC, Kirkwood SC, Foroud T.
    Mov Disord; 2003 Sep 08; 18(9):1027-34. PubMed ID: 14502670
    [Abstract] [Full Text] [Related]

  • 10. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, Dodé C, Brice A, Dürr A.
    Arch Neurol; 2007 Jun 08; 64(6):813-9. PubMed ID: 17562929
    [Abstract] [Full Text] [Related]

  • 11. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.
    Soliveri P, Monza D, Piacentini S, Paridi D, Nespolo C, Gellera C, Mariotti C, Albanese A, Girotti F.
    Neurol Sci; 2002 Sep 08; 23 Suppl 2():S105-6. PubMed ID: 12548365
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease.
    Blekher TM, Yee RD, Kirkwood SC, Hake AM, Stout JC, Weaver MR, Foroud TM.
    Vision Res; 2004 Oct 08; 44(23):2729-36. PubMed ID: 15358067
    [Abstract] [Full Text] [Related]

  • 15. Motor changes in presymptomatic Huntington disease gene carriers.
    Siemers E, Foroud T, Bill DJ, Sorbel J, Norton JA, Hodes ME, Niebler G, Conneally PM, Christian JC.
    Arch Neurol; 1996 Jun 08; 53(6):487-92. PubMed ID: 8660148
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attitudes of persons at risk for Huntington disease toward predictive testing.
    Kessler S, Field T, Worth L, Mosbarger H.
    Am J Med Genet; 1987 Feb 08; 26(2):259-70. PubMed ID: 2949610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy.
    Hessen E, Lossius MI, Reinvang I, Gjerstad L.
    Epilepsy Behav; 2007 May 08; 10(3):449-55. PubMed ID: 17350342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.